Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 59703-00-3 Chemical Structure| 59703-00-3

Structure of 59703-00-3

Chemical Structure| 59703-00-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 59703-00-3 ]

CAS No. :59703-00-3
Formula : C7H9ClN2O3
M.W : 204.61
SMILES Code : O=C(Cl)N1C(C(N(CC)CC1)=O)=O
MDL No. :MFCD00067054
InChI Key :SXVBQOZRZIUHKU-UHFFFAOYSA-N
Pubchem ID :108813

Safety of [ 59703-00-3 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H314
Precautionary Statements:P280-P305+P351+P338-P310
Class:8
UN#:1759
Packing Group:

Application In Synthesis of [ 59703-00-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 59703-00-3 ]

[ 59703-00-3 ] Synthesis Path-Downstream   1~35

  • 1
  • [ 88585-78-8 ]
  • [ 59703-00-3 ]
  • (5R,6S)-6-[(R)-1-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-3-(4-ethyl-2,3-dioxo-piperazine-1-carbonyloxymethyl)-7-oxo-4-thia-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid allyl ester [ No CAS ]
  • 2
  • [ 72699-69-5 ]
  • [ 59703-00-3 ]
  • [ 85208-16-8 ]
YieldReaction ConditionsOperation in experiment
With sodium hydrogencarbonate; sodium hydroxide; In tetrahydrofuran; methanol; water; at 0 - 10℃; for 1.5h; To a solution of the above amino acid (2.06 g, 6 mmol) in THF (60 mL) and water (60 mL) was added a solution of NaOH (480 mg, 12 mmol) in water (5 mL) at 0oC, followed by aqueous saturated NaHCO3 (20 mL), a solution of <strong>[59703-00-3]4-ethyl-2,3-dioxopiperazine-1-carbonyl chloride</strong> (1.54 g, 7.5 mmol) in THF (8 mL), and MeOH (160 mL). The reaction mixture was stirred between 0 - 10 C for 1.5 h, then concentrated in vacuo, acidified with 1 N HCl to pH ~ 2, extracted with EtOAc. The organic extracts were combined, dried over Na2SO4, concentrated in vacuo to afford the crude product, 2.3 g, which was used directly for the next Step without further purification. ESI-MS m/z 476 (M+1)+.
  • 3
  • [ 85208-10-2 ]
  • [ 59703-00-3 ]
  • 6-<(+/-)-α-(2-aminothiazol-4-yl)-α-(4-ethyl-2,3-dioxopiperazin-1-ylcarbonylamino)acetamido>penicillanic acid [ No CAS ]
  • [ 59702-31-7 ]
  • 4
  • [ 73910-42-6 ]
  • [ 59703-00-3 ]
  • [ 73910-43-7 ]
  • 5
  • [ 73910-33-5 ]
  • [ 59703-00-3 ]
  • [ 73910-34-6 ]
  • 6
  • 7β-<(2R)-2-phenyl-2-amino>acetylamino-1-carba-1-dethia-3-cephem-4-carboxylic acid [ No CAS ]
  • [ 59703-00-3 ]
  • 7β-<(2R)-2-phenyl-2-(4-ethyl-2,3-dioxopiperazine-1-yl-carbonyl)amino>acetylamino-1-carba-1-dethia-3-cephem-4-carboxylic acid [ No CAS ]
  • 7
  • [ 161855-50-1 ]
  • [ 59703-00-3 ]
  • (4R,5S,6S)-3-((2R,3R)-2-[(4-Ethyl-2,3-dioxo-piperazine-1-carbonyl)-amino]-methyl}-tetrahydro-furan-3-ylsulfanyl)-6-((R)-1-hydroxy-ethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid [ No CAS ]
  • 8
  • (4R,5S,6S)-3-(5-Aminomethyl-tetrahydro-furan-3-ylsulfanyl)-6-((R)-1-hydroxy-ethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid [ No CAS ]
  • [ 59703-00-3 ]
  • Sodium; (4R,5S,6S)-3-(5-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)-amino]-methyl}-tetrahydro-furan-3-ylsulfanyl)-6-((R)-1-hydroxy-ethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylate [ No CAS ]
YieldReaction ConditionsOperation in experiment
In the same manner as above, a sodium salt of 6-[D(-)-α-(4-ethyl-2,3-dioxo-1-piperazinocarbonylamino)-p-hydroxyphenylacetamido]penicillanic acid, m.p. 175 C (decomp.), yield 72 %, was obtained from 4-ethyl-2,3-dioxo-1-piperazinocarbonyl chloride and a triethylamine salt of 6-[D(-)-α-amino-p-hydroxyphenylacetamido]penicillanic acid.
In the same manner as above, a sodium salt of 6-[D(-)-α-(4-ethyl-2,3-dioxo-1-piperazinocarbonylamino)-p-hydroxyphenylacetamido]penicillanic acid, m.p. 175 C. (decomp.), yield 72%, was obtained from 4-ethyl-2,3-dioxo-1-piperazinocarbonyl chloride and a triethylamine salt of 6-[D(-)-α-amino-p-hydroxyphenylacetamido]penicillanic acid.
  • 10
  • α-amino(3,4-dihydroxyphenyl)acetic acid hydrobromide [ No CAS ]
  • [ 59703-00-3 ]
  • [ 74985-17-4 ]
  • 11
  • [ 5796-17-8 ]
  • [ 59703-00-3 ]
  • (R)-3-(3,4-Dihydroxy-phenyl)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)-amino]-propionic acid [ No CAS ]
  • 12
  • [ 59-92-7 ]
  • [ 59703-00-3 ]
  • [ 263154-16-1 ]
  • 13
  • [ 59703-00-3 ]
  • (3,4-dihydroxy-phenyl)-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)-amino]-acetic acid 2,5-dioxo-pyrrolidin-1-yl ester [ No CAS ]
  • 14
  • [ 59703-00-3 ]
  • (R)-3-(3,4-Dihydroxy-phenyl)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)-amino]-propionic acid 2,5-dioxo-pyrrolidin-1-yl ester [ No CAS ]
  • 15
  • [ 59703-00-3 ]
  • (S)-3-(3,4-Dihydroxy-phenyl)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)-amino]-propionic acid 2,5-dioxo-pyrrolidin-1-yl ester [ No CAS ]
  • 16
  • [ 59703-00-3 ]
  • (2S,3S)-3-{2-(3,4-Dihydroxy-phenyl)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)-amino]-acetylamino}-2-methyl-4-oxo-azetidine-1-sulfonic acid; compound with triethyl-amine [ No CAS ]
  • 17
  • [ 59703-00-3 ]
  • (2S,3S)-3-{(S)-3-(3,4-Dihydroxy-phenyl)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)-amino]-propionylamino}-2-methyl-4-oxo-azetidine-1-sulfonic acid; compound with triethyl-amine [ No CAS ]
  • 18
  • [ 59703-00-3 ]
  • (2S,3S)-3-{(R)-3-(3,4-Dihydroxy-phenyl)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)-amino]-propionylamino}-2-methyl-4-oxo-azetidine-1-sulfonic acid; compound with triethyl-amine [ No CAS ]
  • 19
  • [ 59703-00-3 ]
  • (5R,6S)-3-(4-Ethyl-2,3-dioxo-piperazine-1-carbonyloxymethyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-4-thia-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid allyl ester [ No CAS ]
  • 20
  • [ 59703-00-3 ]
  • Sodium; (5R,6S)-3-(4-ethyl-2,3-dioxo-piperazine-1-carbonyloxymethyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-4-thia-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylate [ No CAS ]
  • 21
  • DL-α-Amino-α-(2-aminobenzothiazol-6-yl)acetic acid [ No CAS ]
  • [ 59703-00-3 ]
  • D-α-[(4-Ethyl-2,3-dioxo-piperazin-1-yl)-carbonylamino]-α-(2-aminobenzothiazol-6-yl)acetic acid [ No CAS ]
YieldReaction ConditionsOperation in experiment
With sodium hydroxide; In tetrahydrofuran; water; acetone; (a) D-α-[(4-Ethyl-2,3-dioxo-piperazin-1-yl)-carbonylamino]-α-(2-aminobenzothiazol-6-yl)acetic acid A suspension of 12 g (0.0538 mol) of D-α-amino-α-(2-aminobenzothiazol-6-yl)acetic acid in 100 ml of tetrahydrofuran (THF) and 40 ml of water is brought into solution by gradual addition of 1N sodium hydroxide up to a pH of 10.5 and cooled to +5 C. to +10 C. 14.3 g (0.0699 mol) of 4-ethyl-2,3-dioxo-1-piperazinocarbonyl chloride dissolved in 80 ml of tetrahydrofuran are added dropwise to the solution. During this time, the pH of the reaction solution is kept at 7.5 to 8.0 by addition of 2N sodium hydroxide. The mixture is subsequently stirred for 2 hours more at room temperature, the pH of the solution is readjusted to 5.0 and the solution is layered onto a column filled with adsorber resin HP 20. Elution takes place using water and 50% strength acetone. The elude, which contains the desired compound, is lyophilized. Yield: 12.8 g (58.2% of theory)
  • 22
  • 2-Chloro-4,5-dihydroxyphenylglycine [ No CAS ]
  • [ 59703-00-3 ]
  • D,L-2-(2-Chloro-4,5-dihydroxyphenyl)-2-(2,3-dioxo-4-ethylpiperazin-1-ylcarbonyl amino)acetic acid [ No CAS ]
YieldReaction ConditionsOperation in experiment
In dichloromethane; water; acetone; N,N-diethyl-1,1,1-trimethylsilanamine; (b) D,L-2-(2-Chloro-4,5-dihydroxyphenyl)-2-(2,3-dioxo-4-ethylpiperazin-1-ylcarbonyl amino)acetic acid D,L-2-Chloro-4,5-dihydroxyphenylglycine (217 mg, 1 mmole) was suspended in trimethylsilyl diethylamine (2 ml), stirred at 80 for 40 minutes then evaporated to dryness in vacuo. The residue in dichloromethane (8 ml) was cooled to -10 then treated dropwise with 2,3-dioxo-4-ethylpiperazin-1-ylcarbonyl chloride (205 mg, 1 mmole) in dichloromehane (1 ml). The reation was stirred for 90 minutes while warming to room temperature then water (5 ml) and acetone were added and the mixture stirred at pH 1.5 for 20 minutes. The mixture was concentrated in vacuo and the aqueous residue adjusted to pH 7.5, washed with ethyl acetate, acidified to pH 1 and extracted with ethyl acetate to give the title compound, 330 mg 85%, mp 208-211 (dec), δ(CD3 OD) 1.16(3H, t, J 7.5 Hz, NCH2 CH3), 3.50 (2H, q, J 7.5 Hz, NCH2 CH3), 3.65 and 3.95 (4H, 2 m, 2*NCH2), 5.63 (1H, d, J 6.5 Hz, CHNH), 6.77(2H, s, Ar), 9.73(1H, d, J6.5 Hz, CHNH).
  • 23
  • D-2-(2-Chloro-4,5-dihydroxyphenyl)glycine [ No CAS ]
  • [ 59703-00-3 ]
  • D,L-2-(2-Chloro-4,5-dihydroxyphenyl)-2-(2,3-dioxo-4-ethylpiperazin-1-ylcarbonyl amino)acetic acid [ No CAS ]
YieldReaction ConditionsOperation in experiment
With chloro-trimethyl-silane; In tetrahydrofuran; 1,1,1,3,3,3-hexamethyl-disilazane; (b) D-2-(2-Chloro-4,5-dihydroxyphenyl)-N-(2,3-dioxo-4-ethylpiperazin-1-ylcarbonyl)glycine D-2-(2-Chloro-4,5-dihydroxyphenyl)glycine (2.97 g) and chlorotrimethylsilane (1 ml) in hexamethyldisilazane (36 ml) were refluxed under an atmosphere of nitrogen for 2 hours, then evaporated in vacuo. The residue was dissolved in THF (20 ml) and cooled in an ice-bath. A solution of 2,3-dioxo-4-ethylpiperazin-1-ylcarbonyl chloride (3.1 g) in THF (20 ml) was added dropwise over 0.5 hours. The mixture was allowed to gain room temperature and stirred for 1 hour, diluted with ethyl acetate (150 ml), butanol (20 ml), water (150 ml) and stirred for a further 20 minutes. The aqueous was discarded and the organic phase washed with water (4*100 ml), dried and evaporated in vacuo 3.7 g, 81% δ[(CD3)2 CO]1.15(3H, t, J6 Hz, NCH2 CH3), 3.50(2H, q, J6 Hz, NCH2 CH3), 3.70, 4.05(4H, 2*m, NCH2 CH2 N), 5.81 (1H, d, J7 Hz, CHNH), 6.91, 6.94, (2H, 2*s, Ar), 9.80 (1H, d, J7 Hz, CHNH).
  • 24
  • 2-amino-2-(1,2,3-thiadiazol-4-yl)acetic acid hydrochloride [ No CAS ]
  • [ 59703-00-3 ]
  • DL-2-(4-ethyl-2,3-dioxopiperazin-1-ylcarbonylamino)-2-(1,2,3-thiadiazol-4-yl)acetic acid [ No CAS ]
YieldReaction ConditionsOperation in experiment
(a) DL-2-(4-Ethyl-2,3-dioxopiperazin-1-ylcarbonylamino)-2-(1,2,3-thiadiazol-4-yl)acetic acid The title compound (1.24 g) was prepared from 2-amino-2-(1,2,3-thiadiazol-4-yl)acetic acid hydrochloride [Example 3(a)] (912 mg) and 4-ethyl-2,3-dioxopiperazin-1-ylcarbonyl chloride (953 mg) by the method of Example 1(a). NMR (DMSO-d6) δ=1.06 (t, 3H, J=7 Hz); 3.37 (q, 2H, J=7 Hz); 3.56 (m, 2H); 3.94 (m, 2H); 6.04 (d, 2H, J=6 Hz); 9.26 (s, 1H); 10.01 (d, 1H, J=6 Hz).
  • 25
  • cefalexin [ No CAS ]
  • [ 59703-00-3 ]
  • 3-methyl-7-[2-phenyl-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)acetamido]ceph-3-em-4-carboxylic acid [ No CAS ]
YieldReaction ConditionsOperation in experiment
With potassium carbonate; In water; ethyl acetate; PREPARATION 25 3-Methyl-7-[2-phenyl-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)acetamido]ceph-3-em-4-carboxylic Acid Cephalexin (696 mg., 2 mmoles) was dissolved in 10 ml. of water at 5 C. by the action of potassium carbonate (304 mg., 2.2 mmoles). Ethyl acetate (5 ml.) was added and then <strong>[59703-00-3]4-ethyl-2,3-dioxopiperazine-1-carbonyl chloride</strong> (450 mg., 2.2 mole) was added over a period of 15 minutes at 0-5 C. After addition was complete, the reaction mixture was stirred for an additional 30 minutes, at which time the ethyl acetate layer was separated and the aqueous phase washed with an additional portion of ethyl acetate. The aqueous phase was adjusted to 2.5 and the product extracted into several portions of fresh ethyl acetate. The acidic ethyl acetate extracts were combined, back-washed with water, washed with brine, dried over anhydrous magnesium sulfate, evaporated to dryness in vacuo, and the residue crystallized from methylene chloride to yield 3-methyl-7-[2-phenyl-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)acetamido]ceph-3-em-4-carboxylic acid (568 mg., m.p. 199-200 C.).
  • 26
  • [ 859451-00-6 ]
  • [ 59703-00-3 ]
  • [ 74985-17-4 ]
YieldReaction ConditionsOperation in experiment
In tetrahydrofuran; N,N-diethyl-1,1,1-trimethylsilanamine; (a) D-2-[(4-Ethyl-2,3-dioxopiperazin-1-yl)carbonylamino]-2-(3,4-dihydroxyphenyl)acetic acid D-3,4-Dihydroxyphenylglycine (1.00 g, 5.46 mmole) was suspended in N,N-diethyl-1,1,1,-trimethylsilylamine (10 ml) and heated at 80-90 C. under nitrogen for 3 h. There was undissolved solid at the end of this period. Excess reagent was removed by evaporation under high vacuum and the residue was suspended in dry tetrahydrofuran (10 ml). The mixture was stirred at 0 C. and <strong>[59703-00-3]4-ethyl-2,3-dioxopiperazine-1-carbonyl chloride</strong> (1.23 g, 1.1 eq) was added in one portion. The mixture was allowed to warm to room temperature and stirring was continued for 1 h. After this time the mixture was poured into water (resulting pH2) and extracted with 1:1 n-butanol:ethyl acetate. The aqueous phase was saturated with brine and further extracted twice with the same solvent mixture, then the combined extracts were dried over sodium sulphate. Evaporation gave an oil which on trituration with ether afforded the title acid as a light brown solid which retained solvents tenaciously (1.9 g, 99% ignoring solvent); Rf 0.35 in n-butanol:acetic acid:water, 4:1:1, [α]D20 -81.7 (c 1.0 in EtOH); νmax (KBr) 1710, 1670, 1610, 1520 cm-1; δ[(CD3)2 SO] 1.07 (3H, t, J8 Hz, CH3 CH2 N), 3.0-3.7 (4H, m, 2CH2 N), 3.7-4.0 (2H, m, CH2 N), 5.10 (1H, d, J 7 Hz, NCH(Ar)CO), 6.5-6.9 (3H, m, aryls), 9.0 (2H, br, D2 O exch, phenolic OH), 9.60 (1H, br s, J 7 Hz, NH).
  • 27
  • t-butyl 7β-(D-2-amino-2-phenylacetamido)-7α-formamidocephalosporanate [ No CAS ]
  • [ 59703-00-3 ]
  • t-Butyl 7β-[D-2-[(4-Ethyl-2,3-dioxopiperazin-1-yl)carbonylamino]-2-phenylacetamido]-7α-formamidocephalosporanate [ No CAS ]
YieldReaction ConditionsOperation in experiment
22% With pyridine; In dichloromethane; (c) t-Butyl 7β-[D-2-[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonylamino]-2-phenylacetamido]-7α-formamidocephalosporanate A solution of 4-ethyl-2,3-dioxopiperazine-carbonyl chloride (0.021 g, 0.1 mmol) in dichloromethane (5 ml) was added dropwise to a stirred solution of t-butyl 7β-(D-2-amino-2-phenylacetamido)-7α-formamidocephalosporanate (0.050 g, 0.1 mmol) and pyridine (0.012 g, 0.15 mmol) in dichloromethane (5 ml) at 0 C. The reaction solution was stirred at 0-5 C. for 0.5 h, followed by 2 h at room temperature. It was then washed with 0.5N. hydrochloric acid, dilute aqueous sodium hydrogen carbonate and brine, and dried over magnesium sulphate. It was evaporated to dryness, and the residue chromatographed on silica gel 60 (<230 mesh ASTM) eluding with 5% ethanol/ethyl acetate to afford the title compound (0.015 g, 22%).
  • 28
  • D-3,4-Dihydroxyphenyl glycine [ No CAS ]
  • [ 59703-00-3 ]
  • [ 74985-17-4 ]
YieldReaction ConditionsOperation in experiment
40% With chloro-trimethyl-silane; In dichloromethane; water; acetone; 1,1,1,3,3,3-hexamethyl-disilazane; (a) D-2-(4-Ethyl-2,3-dioxopiperazine-1-carbonylamino)-2-(3,4-dihydroxyphenyl) acetic acid D-3,4-Dihydroxyphenyl glycine (0.92 g, 5 mmol) in 1,1,1,3,3,3-hexamethyl-disilazane (8 ml) and trimethylsilyl chloride (2 ml) was heated, in an inert atmosphere, under reflux for 2 hours. Excess silylating agents and by products were removed by evaporation in vacuo and the residue was dissolved in dry dichloromethane (10 ml). The solution was cooled to 0 C. when <strong>[59703-00-3]4-ethyl-2,3-dioxopiperazine-1-carbonyl chloride</strong> (10 mg, 5 mmol) in dry dichloromethane (5 ml) was added. The mixture was stirred for 1.5 hours at 21 0 C., evaporated to low bulk and the residue dissolved in 2:1 acetone/water (30 ml) at pH 1.5 with vigorous stirring. After 0.3 hours the acetone was evaporated, the residue basified to pH 7.5 with dilute sodium bicarbonate and washed with ethyl acetate. The aqueous phase was saturated with sodium chloride, layered with ethyl acetate and acidified to pH 2 with dilute hydrochloric acid. The aqueous phase was separated, extracted several times with ethyl acetate and the combined organic phases, washed with brine dried (MgSO4) and evaporated to give a white solid (0.7 g, 40%). IR νmax (Nujol) 3300 (b), 2950 (b), 1720, 1690 cm-1 Pmr δ(d6 acetone/D2 O) 6.9 (3H, m, aryl protons), 5.4 (1H, s, CH), 4.3-3.4 (6H, m, CH2 CH2, CH2 CH3) and 1.3 (3H, t, CH2 CH3)ppm.
27% With hydrogenchloride; In diethyl ether; dichloromethane; ethyl acetate; acetone; N,N-diethyl-1,1,1-trimethylsilanamine; (a) D-2(4-Ethyl-2,3-dioxopiperazine-1-carbonylamino)-2-(3,4-dihydroxyphenyl)acetic acid D-3,4-Dihydroxyphenyl glycine (2.5 g, 13.7 mmol) in trimethylsilyldiethylamine (15 ml) under nitrogen was heated under reflux for 0.3 h. The solution was evaporated to dryness and the residue dissolved in dry dichloromethane (20 ml), cooled to 0 C. and then treated with a solution of 4-ethyl-2,3-dioxopiperazine-1-carbonylchloride (2.7 g, 13.7 mmol) in dichloromethane (10 ml). The mixture was allowed to warm to 21 C., stirred for 1 h, poured into water (50 ml) and stirred for a further 0.2 h. The aqueous phase was basified to pH 7.5 and the organic phase then separated and discarded. Acidification of the aqueous solution to pH 1.5 with dilute hydrochloric acid followed by extraction with 10% n-butanol in ethyl acetate (3*50 ml), drying of the combined extracts (MgSO4) and evaporation gave an off-white foam. This product dissolved in acetone (10 ml) was dropped into diethyl ether (100 ml) with vigorous stirring to give the title compound as a solid (1.3 g, 27%) m.p. softens above 115 C. melts 140-145 C. (dec), νmax (Nujol) 3300 (br), 1710, 1675, 1520 cm-1 δ(d6 -acetone 9.8 (1H, d, J 7 Hz, NH), 6.9 (3H, m, aryl protons), 5.4 (4H, m, reduces to 1H, s, CHCO2 H, on the additon D2 O), 4.2-3.3 (6H, m, CH2 -CH2, CH2 CH3) and 1.2 (3H, t, J 7 Hz, CH2 CH3) ppm.
  • 29
  • [ 83628-42-6 ]
  • [ 59703-00-3 ]
  • 4-[3-(2,3-dioxo-4-ethylpiperazine-1-carbonylamino)propyl]-2-fluoro-1-triphenylmethylimidazole [ No CAS ]
YieldReaction ConditionsOperation in experiment
With dmap; In dichloromethane; Crude 4-(3-aminopropyl)-2-fluoro-1-triphenylmethylimidazole was dissolved in CH2 Cl2 and treated with 4-dimethylaminopyridine and a solution of 1-chlorocarbonyl-4-ethylpiperazine-2,3-dione in CH2 Cl2. Work-up by chromatography gave 4-[3-(2,3-dioxo-4-ethylpiperazine-1-carbonylamino)propyl]-2-fluoro-1-triphenylmethylimidazole, having the following n.m.r. spectrum in CDCl3: 1.25 (t, 3H); 1.85 (quintet, 2H); 2.25-3.7 (m, 6H); 4.05 (q, 2H); 6.25 (s, 1H); 7.05-7.5 (m, 15H).
  • 30
  • [ 75-44-5 ]
  • [ 59702-31-7 ]
  • [ 59703-00-3 ]
YieldReaction ConditionsOperation in experiment
With chloro-trimethyl-silane; triethylamine; In tetrahydrofuran; 1,4-dioxane; (2)--To a suspension of 0.71 g of the abovementioned 1-ethyl-2,3-dioxo-piperazine in 15 ml of anhydrous dioxane were added with stirring 0.70 g of trimethylsilyl chloride and 0.83 ml of triethylamine. The resulting mixture was stirred at room temperature for 20 hours to deposit triethylamine hydrochloride. This hydrochloride was separated by filtration, and the filtrate was dropped at 5 to 10 C. into a solution of 0.70 g of phosgene in 10 ml of anhydrous tetrahydrofuran. Subsequently, the resulting mixture was reacted at 5 to 10 C. for 30 minutes and at room temperature for 2 hours, and then the solvent was removed by distillation under reduced pressure to obtain 1.0 g of pale yellow crystals of 4-ethyl-2,3-dioxo-1-piperazinocarbonyl chloride. IR (KBr) cm-1: -- νC=O 1780, 1660
  • 31
  • [ 149-30-4 ]
  • [ 120600-74-0 ]
  • [ 59703-00-3 ]
YieldReaction ConditionsOperation in experiment
With triethylamine; In dichloromethane; Example 5 S-2-benzothiazolyl-4-ethyl-2,3-dioxo-1-piperazinethiocarboxylate 2-mercaptobenzothiazole (16.7g; 0.1 mole) is suspended in methylene chloride (500 ml) and triethylamine (14 ml; 0.1 mole) is added at room temperature under stirring. After the solution is formed 4-ethyl-2,3-dioxo-1-piperazine-carbonylchloride (20.4 g; 0.1 mole) is added under stirring. The reaction mixture is stirred for another 4 hours at room temperature, filtered and the obtained product is washed with acetone (50 ml). After drying in an air-drier S-2-benzothiazolyl-4-ethyl-2,3-dioxo-1-piperazinethiocarboxylate (30 g; yield 93 %) with m.p. 217-220C is obtained.
  • 32
  • [ 3228-02-2 ]
  • [ 59703-00-3 ]
  • 4-isopropyl-3-methylphenyl N-(4-ethyl-2,3-dioxo-1-piperazine)carbamate [ No CAS ]
YieldReaction ConditionsOperation in experiment
92.0% With triethylamine; In acetonitrile; at 20℃; for 4h; <Example 19> Synthesis of 4-isopropyl-3-methylphenyl N- (4-ethyl-2 , 3-dioxo-l-piperazine) carbamate2 g (13.31 mmol) of 4-isopropyl-3-methylphenol were dissolved in 15 ml of acetonitrile, to obtain a reaction solution, which was then added with 2.22 ml of triethylamine and 3.02 g (14.75 mmol) of 4-ethyl-2,3- dioxo-1-piperazinecarbonyl chloride and stirred at room temperature for 4 hr. After the completion of the reaction, the same procedures as in Example 1 were conducted, thus yielding 3.90 g (92.0%) of 4-isopropyl-3- methylphenyl N- (4-ethyl-2, 3-dioxo-l-piperazine) carbamate as a title compound. IR(KBr, cm"1) : 1783(C=O), 1675 (C=O) 1H-NMR (CDCl3, ppm) : 1.19(m, 9H, isopropyl CH (CH3) 2, N- CH2CH3), 2.31 (s, 3H, 3-CH3), 3.10 (m, IH, isopropyl CH(CH3J2), 3.60(m, 4H, piperazine ring CH2CH2), 4.12 (m, 2H, N-CH2CH3), 6.95(s, 2H, aromatic 2-H, 6-H) , 7.21 (s, IH, aromatic 5-H)
  • 33
  • [ 1364569-65-2 ]
  • [ 59703-00-3 ]
  • [ 1364569-75-4 ]
YieldReaction ConditionsOperation in experiment
22% With triethylamine; In dichloromethane; N,N-dimethyl-formamide; at 20℃; To a suspension of 6 (0.1 g, 0.3 mmol) in CH2Cl2 (3 mL), TEA (3 mL) and DMF (1 mL) was added 1,4-dioxopiperadinyl chloride (0.1 g, 0.5 mmol) at room temperature, and the mixture was allowed to stir overnight. The reaction mixture was concentrated in vacuo and dilluted with CHCl3. The solution was successively washed with satd. NaHCO3 and brine, dried, and concentrated. The residue was purified by silica gel column chromatography (CHCl3/MeOH = 9:1) to give a yellow solid 7b (0.03 g, 0.05 mmol, 22%). mp 60-63C. 1H NMR (DMSO-d6, 399.65 MHz) δ: 1.39 (3H, t, J = 7.2 Hz), 3.94-4.40 (8H, m), 7.15-7.60 (6H, m) 7.99-8.31(4H, m), 9.40 (1H, s), 11.55 (1H, s). ESI-MS m/z: 520.0 (M-H)-; HR-FAB-MS m/z: (M+H)+ calcd for C25H24N5O6S, 522.1369; found, 522.1459.
  • 34
  • 2-(3-[5-(2-aminoethoxy)benzothiazol-2-ylmethyl]amino}-[1,2,4]triazin-5-yl)-3-methylphenol hydrochloride [ No CAS ]
  • [ 59703-00-3 ]
  • [ 1426097-00-8 ]
  • 35
  • C18H19N7O5S2 [ No CAS ]
  • [ 59703-00-3 ]
  • cefoperazone [ No CAS ]
YieldReaction ConditionsOperation in experiment
42% With potassium carbonate; In water; ethyl acetate; at 20℃; D -7-(4-Hydroxyphenylacetamido)-3-(1-methyl-1H-tetrazol-5-yl)thiomethylcephem-4-carboxylic acid (500 mg) was suspended at room temperature in water (10 mL). After addition of potassium carbonate (230 mg, 1.5 equiv.) the suspension became a clear solution. To this mixture, ethyl acetate (5 mL) and ethyl-2,3-dioxo-1-piperazinecarbonylchloride (210 mg, 1 equiv.) were added. After stirring overnight, the reaction was analyzed by analytical HPLC showing 42% of the desired product cefoperazone based on the starting material.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 59703-00-3 ]

Chlorides

Chemical Structure| 112489-86-8

A809686 [112489-86-8]

4-Methyl-3,5-dioxopiperazine-1-carbonyl chloride

Similarity: 0.92

Amides

Chemical Structure| 112489-86-8

A809686 [112489-86-8]

4-Methyl-3,5-dioxopiperazine-1-carbonyl chloride

Similarity: 0.92

Acyl Chlorides

Chemical Structure| 112489-86-8

A809686 [112489-86-8]

4-Methyl-3,5-dioxopiperazine-1-carbonyl chloride

Similarity: 0.92

Related Parent Nucleus of
[ 59703-00-3 ]

Piperazines

Chemical Structure| 112489-86-8

A809686 [112489-86-8]

4-Methyl-3,5-dioxopiperazine-1-carbonyl chloride

Similarity: 0.92